Previous Close | 0.2155 |
Open | 0.2155 |
Bid | 0.1956 x 2200 |
Ask | 0.2000 x 1000 |
Day's Range | 0.1820 - 0.2155 |
52 Week Range | 0.1820 - 0.9400 |
Volume | |
Avg. Volume | 349,840 |
Market Cap | 21.546M |
Beta (5Y Monthly) | 1.53 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2100 |
Earnings Date | Dec 17, 2024 - Dec 23, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 1.00 |
SEATTLE, October 02, 2024--Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards. A Plan for Compliance has been undertaken
SEATTLE, September 10, 2024--Peer-reviewed journal publication validates Know Labs’ proprietary technology and its application for non-invasive blood glucose monitoring.
SEATTLE, August 16, 2024--Know Labs, Inc. (NYSE American: KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive agreements with certain investors to purchase 6,365,385 Units for an aggregate offering of $1.655 million at a public offering price of $0.26 per unit, with each unit consisting of one share of its common stock and one warrant to purchase one share of its common stock at an initial exercise price of